Featured News

The lecture "Non-celiac gluten sensitivity: what is the evidence?", hosted by Celiac Disease Center at Columbia University, will be held at the Faculty House at Columbia University on January 15, 2020. The lecture will be presented by the Celiac Disease Foundation's Young Investigator Award recipient, Benjamin Lebwohl, MD.

Cour Pharmaceuticals has announced a $420 million licensing deal with Takeda Pharmaceuticals following a favorable outcome of their phase 2 trial for celiac disease. The company released data from a…

Parents using multiple kitchen appliances and utensils to prevent their child with celiac disease from being exposed to gluten may be able to eliminate some cumbersome steps. A new, preliminary…

Researchers found that children with celiac disease have a 1.2-1.8 higher risk of psychological conditions such as depression, mood disorders, behavioral problems, ADHD, eating disorders, autism, and other intellectual disabilities.

Researchers are collecting blood samples to help develop new diagnostics that may not require gluten ingestion or a biopsy to confirm the diagnosis. 

ActoBio announces FDA has given permission to an Investigational New Drug (IND) application for Actobiotics® AG017, a therapeutic candidate for celiac disease.

Often, when a patient is following a long-term gluten-free diet with good compliance, micronutrient deficiencies cannot be detected. This review - published in the scientific journal Medicina - evaluates the most recent literature on micronutrient deficiencies in patients following a long-term gluten-free diet in order to provide dietary supplementation advice. The study concludes that in patients with micronutrient deficiencies caused by celiac disease, vitamin supplements may be necessary.